<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04038879</url>
  </required_header>
  <id_info>
    <org_study_id>555087</org_study_id>
    <nct_id>NCT04038879</nct_id>
  </id_info>
  <brief_title>Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation</brief_title>
  <official_title>Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlantic Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atlantic Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary treatment for patients determined to have severe aortic or mitral regurgitation
      is surgical repair or replacement their valves. The most commonly used tool to quantify the
      severity mitral and aortic regurgitation is echocardiography. Studies have shown that
      echocardiography may have significant limitations in quantifying regurgitant volume. MRI has
      recently been shown to easily and reproducibly quantify regurgitation. To better understand
      how to accurately quantify severity of regurgitation the investigators propose this study
      with the following aims: 1) compare MRI to echocardiography in the evaluation of regurgitant
      volume in patients with aortic or mitral regurgitation and 2) to assess which technique is
      better at predicting the response of the left ventricle to valve surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary treatment for patients determined to have severe aortic or mitral regurgitation
      is surgical repair or replacement their valves. The most commonly used tool to quantify the
      severity mitral and aortic regurgitation is echocardiography. Studies have shown that
      echocardiography may have significant limitations in quantifying regurgitant volume. MRI has
      recently been shown to easily and reproducibly quantify regurgitation. To better understand
      how to accurately quantify severity of regurgitation the investigators propose this study
      with the following aims: 1) compare MRI to echocardiography in the evaluation of regurgitant
      volume in patients with aortic or mitral regurgitation and 2) to assess which technique is
      better at predicting the response of the left ventricle to valve surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2010</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of echocardiography and MRI</measure>
    <time_frame>6 month</time_frame>
    <description>Correlation of echocardiography and MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in LV EDV post surgery</measure>
    <time_frame>6 month</time_frame>
    <description>Change in LV EDV post surgery</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Mitral Regurgitation</condition>
  <condition>Aortic Regurgitation</condition>
  <arm_group>
    <arm_group_label>Mitral/Aortic Regurgitation</arm_group_label>
    <description>Subjects identified with mitral or aortic regurgitation will be asked to undergo testing with trans thoracic echocardiogram, stress echocardiography, and cardiac MRI with and without contrast. In addition, patients will be asked to answer the KCC and EQ5DL questionnaires.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>MRI of the heart</description>
    <arm_group_label>Mitral/Aortic Regurgitation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with mitral or aortic regurgitation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥18 years of age

          -  Able to give informed consent

          -  Referred for isolated aortic or mitral valve repair or replacement due to valve
             regurgitation

        Exclusion Criteria:

          -  Inability to provide consent.

          -  Pregnancy

          -  Claustrophobia

          -  Metallic contraindications to MRI (e.g. noncompatible aneurysm clip etc)

          -  Known intracardiac shunt

          -  Planned concomitant cardiac surgical procedure such as coronary artery bypass, septal
             myomectomy, or other valve procedure.

          -  More than mild mitral or aortic stenosis.

          -  For patients enrolled with mitral regurgitation: greater than mild aortic
             regurgitation.

          -  For patients enrolled with aortic regurgitation: greater than mild mitral
             regurgitation.

          -  Hypertrophic cardiomyopathy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seth Uretsky, MD</last_name>
      <phone>973-971-5597</phone>
      <email>seth.uretsky@atlantichealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Miller, RN</last_name>
      <phone>9739715597</phone>
      <email>susan.miller@atlantichealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Seth Uretsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Uretsky S, Aldaia L, Marcoff L, Koulogiannis K, Hiramatsu S, Argulian E, Rosenthal M, Gillam LD, Wolff SD. The Effect of Systolic Variation of Mitral Regurgitation on Discordance Between Noninvasive Imaging Modalities. JACC Cardiovasc Imaging. 2019 Dec;12(12):2431-2442. doi: 10.1016/j.jcmg.2019.02.014. Epub 2019 Apr 17.</citation>
    <PMID>31005539</PMID>
  </reference>
  <reference>
    <citation>Uretsky S, Argulian E, Supariwala A, Marcoff L, Koulogiannis K, Aldaia L, Chaudhry FA, Wolff SD, Gillam LD. A Comparative Assessment of Echocardiographic Parameters for Determining Primary Mitral Regurgitation Severity Using Magnetic Resonance Imaging as a Reference Standard. J Am Soc Echocardiogr. 2018 Sep;31(9):992-999. doi: 10.1016/j.echo.2018.04.006. Epub 2018 Jun 18.</citation>
    <PMID>29921479</PMID>
  </reference>
  <reference>
    <citation>Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A, Gurram S, Jain K, Subero M, Jang JJ, Cohen R, Wolff SD. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol. 2015 Mar 24;65(11):1078-88. doi: 10.1016/j.jacc.2014.12.047.</citation>
    <PMID>25790878</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 28, 2019</study_first_submitted>
  <study_first_submitted_qc>July 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atlantic Health System</investigator_affiliation>
    <investigator_full_name>Seth Uretsky</investigator_full_name>
    <investigator_title>Medical Director, Cardiovascular Imaging</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
    <mesh_term>Aortic Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

